Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome.

Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Abstract Text:

    e o adeyemiE O Adeyemi,e n obinecheE N Obineche,a s abdulleA S Abdulle,a r osmanA R Osman,

    In patients with the nephrotic syndrome, it is often desirable to assess the disease process, not only by proteinuria but also by indices of glomerular inflammatory process. We investigated the importance of beta-microglobulin (betaM) as a means of assessing renal function in patients with the nephrotic syndrome with normal or abnormal values of creatinine clearance. There were 46 patients (mean age, 42.2 + 10.4 years; male/female (M/F) ratio = 31/15) and 35 healthy controls (mean age 39 + 4.5 years, M/F ratio 25/10). We subdivided the study patients into group A (n = 18, mean age 39.6 + 10.6 years, M/F ratio 8/10) and group B patients (n = 28, mean age 45.6 + 8.9 years, M/F ratio 23/5) who had normal and abnormal values of creatinine clearance respectively. An enzyme-linked-immunosorbent assay (ELISA) was used to quantitate plasma beta2M in the study patients and controls. The median 132M levels of the study patients and controls were 44.0 and 1.7 mg/l respectively (p < 0.0001). Beta-2-M levels correlated significantly with serum creatinine (r = 0.56, p < 0.0001), and creatinine clearance (r = -0.6, p < 0.0001). In group A patients, the median beta2M level was significantly higher than normal (4.1 vs. 1.7 mg/1, p < 0.01). Plasma beta2M levels did not correlate well with any other parameter measured in group A patients. When groups A and B were compared, the median plasma beta2M level in group B was significantly higher than group A (20.3 vs. 4.1 mg/1, p < 0.0001). The urinary beta2M (expressed per mg urine creatinine) was also higher in group B than group A patients (6.8 vs. 0.7 p < 0.05). We conclude that elevation of beta2M-microglobulin in patients with the nephrotic syndrome who have normal creatinine clearance suggests early abnormal renal function in these patients. It may be used to assess the rate of normalisation of renal function or progression to chronic renal failure.

    Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Publishing Authors By Initials

    eo adeyemiEO Adeyemi,en obinecheEN Obineche,as abdulleAS Abdulle,ar osmanAR Osman,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Saudi journal of kidney diseases and transplantati

    VOLUME: 12

    Page Numbers: 151-6

    Journal Abbreviation:

    ISSN: 1319-2442

    DAY: 22

    MONTH: 01

    YEAR: 2008

    Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9436968

    Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome.

    AFFILIATION: Department of Medicine, Faculty of Medicine & Health Sciences, UAE University, United Arab Emirates.

    Country: Saudi Arabia

    Saudi Arabia Research PublicationSaudi Arabia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Saudi J Kidney Dis Transpl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Evaluation of Plasma Beta-2-microglobulin in Patients with the Nephrotic Syndrome Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News